πππWeili Zhibo
$LEADS BIOLABS-B(09887)$ also known as Leads Biolabs is a Chinese clinical stage biotechnology company, specialising in next generation immuno-oncology therapies.
This is an exciting IPO as Leads Biolabs is a front runner in Immuno-Oncology 2.0 with its integrated R&D and clinical capabilities.
Already Leads Biolabs has been backed by major investors such as Tencent $TENCENT(00700)$ showing that it is a worthwhile company to invest in.
I have put Leads Biolabs in my watch list as it has lots of upside potential with new cutting edge cancer treatments.
@Tiger_comments @TigerStars @Tiger_SG @CaptainTiger
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments